SEOUL, Jan. 9 (Korea Bizwire) — Scientists have discovered that the brain region associated with movement disorders like ...

BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE ...

Mytos' automated cell culture technology will power manufacturing of dopaminergic neuronal precursor cells for Aspen's investigational cell therapy ANPD001 in Parkinson's disease Mytos, an innovative ...